0001368458--09-30Q2falseApril 30, 2026http://fasb.org/srt/2025#ChiefExecutiveOfficerMember0001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:StylingToolsAndSuppliesMember2025-01-012025-03-310001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMembersbh:HairCareMember2026-01-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMembersbh:HairColorMember2025-10-012026-03-310001368458sbh:SallyHoldingsMembersbh:TLBTwentyThirtyMember2026-01-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:OtherBeautyItemsMembersbh:SallyMember2024-10-012025-03-310001368458us-gaap:FairValueInputsLevel2Membersbh:SeniorNotesDueTwoThousandAndThirtytwoMember2025-09-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMembersbh:BeautySystemsGroupMemberus-gaap:EntityOperatedUnitsMember2025-10-012026-03-310001368458us-gaap:CommonStockMember2024-09-300001368458us-gaap:FairValueInputsLevel2Membersbh:SeniorNotesDueTwoThousandAndThirtytwoMember2026-03-310001368458us-gaap:OperatingSegmentsMember2025-01-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:StylingToolsAndSuppliesMembersbh:SallyMember2025-10-012026-03-310001368458us-gaap:RetainedEarningsMember2026-03-310001368458sbh:SallyBeautySupplyMemberus-gaap:OperatingSegmentsMember2024-10-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:OtherBeautyItemsMembersbh:SallyMember2025-01-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:NailMember2026-01-012026-03-310001368458sbh:ShareRepurchaseProgram2017Member2026-03-310001368458us-gaap:SalesRevenueNetMembersbh:SkinAndCosmeticsMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2025-01-012025-03-310001368458us-gaap:FairValueInputsLevel2Memberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2025-09-300001368458us-gaap:FairValueInputsLevel2Memberus-gaap:OtherAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2026-03-310001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:HairColorMember2025-10-012026-03-310001368458currency:EUR2026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:ECommerceMember2026-01-012026-03-310001368458currency:GBP2026-03-310001368458us-gaap:ForeignExchangeContractMember2025-10-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMember2025-10-012026-03-310001368458us-gaap:CommonStockMember2025-09-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:ECommerceMember2024-10-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:StylingToolsAndSuppliesMembersbh:BeautySystemsGroupMember2025-01-012025-03-310001368458us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeContractMember2024-10-012025-03-310001368458us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001368458us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2025-10-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:SalonBusinessConsultantsMember2025-01-012025-03-310001368458us-gaap:SalesRevenueNetMembersbh:OtherBeautyItemsMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2025-10-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMembersbh:HairColorMember2025-01-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:ECommerceMember2025-01-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:HairColorMember2024-10-012025-03-310001368458sbh:DentonTexasMember2024-10-310001368458us-gaap:RetainedEarningsMember2025-03-310001368458us-gaap:AccumulatedTranslationAdjustmentMember2025-10-012026-03-310001368458us-gaap:FranchisedUnitsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMember2025-01-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMembersbh:SallyMemberus-gaap:EntityOperatedUnitsMember2025-01-012025-03-310001368458us-gaap:ForeignExchangeContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2025-10-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMembersbh:BeautySystemsGroupMemberus-gaap:EntityOperatedUnitsMember2026-01-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:ECommerceMember2025-10-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:StylingToolsAndSuppliesMembersbh:BeautySystemsGroupMember2024-10-012025-03-310001368458sbh:DentonTexasMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-10-012025-03-310001368458sbh:ShareRepurchaseProgram2017Member2026-01-012026-03-310001368458us-gaap:InterestRateSwapMembersbh:SallyHoldingsMember2026-01-012026-03-310001368458us-gaap:RetainedEarningsMember2024-10-012024-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:StylingToolsAndSuppliesMember2024-10-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:OtherBeautyItemsMembersbh:BeautySystemsGroupMember2026-01-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMembersbh:SallyMemberus-gaap:EntityOperatedUnitsMember2024-10-012025-03-3100013684582025-12-310001368458us-gaap:InterestRateSwapMember2026-03-310001368458us-gaap:ForeignExchangeContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2025-01-012025-03-310001368458us-gaap:AdditionalPaidInCapitalMember2024-09-3000013684582026-01-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:SalonBusinessConsultantsMember2026-01-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:NailMembersbh:BeautySystemsGroupMember2026-01-012026-03-3100013684582025-01-012025-03-310001368458sbh:AccumulatedForeignExchangeContractsMember2025-10-012026-03-3100013684582025-10-012025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:HairCareMember2025-10-012026-03-310001368458us-gaap:InterestRateSwapMembersbh:SallyHoldingsMember2025-10-012026-03-310001368458us-gaap:InterestRateSwapMembersbh:SallyHoldingsMember2026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:ECommerceMember2025-10-012026-03-310001368458us-gaap:DesignatedAsHedgingInstrumentMembercurrency:MXN2026-03-310001368458us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2025-09-3000013684582026-01-312026-01-310001368458us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeContractMember2025-01-012025-03-310001368458us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2026-03-310001368458us-gaap:InterestRateSwapMember2025-09-300001368458us-gaap:FranchisedUnitsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMember2026-01-012026-03-3100013684582026-05-060001368458us-gaap:ForeignExchangeContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-10-012025-03-310001368458sbh:ShareRepurchaseProgram2017Member2024-10-012025-03-310001368458us-gaap:CommonStockMember2025-01-012025-03-310001368458sbh:SallyBeautySupplyMemberus-gaap:OperatingSegmentsMember2026-01-012026-03-310001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-10-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMembersbh:HairColorMember2026-01-012026-03-310001368458us-gaap:AccumulatedTranslationAdjustmentMember2026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMembersbh:SallyMemberus-gaap:EntityOperatedUnitsMember2026-01-012026-03-310001368458us-gaap:CommonStockMember2026-03-310001368458us-gaap:OperatingSegmentsMembersbh:BeautySystemsGroupMember2025-01-012025-03-310001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001368458us-gaap:SalesRevenueNetMembersbh:SkinAndCosmeticsMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2026-01-012026-03-3100013684582025-09-300001368458us-gaap:OperatingSegmentsMembersbh:BeautySystemsGroupMember2024-10-012025-03-3100013684582024-10-012024-12-310001368458sbh:UnallocatedMember2024-10-012025-03-310001368458us-gaap:CommonStockMember2024-10-012024-12-310001368458sbh:UnallocatedMember2026-01-012026-03-310001368458us-gaap:SalesRevenueNetMembersbh:SkinAndCosmeticsMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMember2025-10-012026-03-310001368458sbh:UnallocatedMember2025-10-012026-03-310001368458us-gaap:FairValueInputsLevel2Membersbh:TermLoanBDueTwoThousandAndThirtyMember2026-03-310001368458sbh:ShareRepurchaseProgram2017Member2025-10-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2025-10-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMember2024-10-012025-03-310001368458us-gaap:FairValueInputsLevel2Memberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:ECommerceMember2025-01-012025-03-3100013684582025-03-310001368458us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:AccruedLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:HairCareMember2025-01-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMembersbh:HairCareMember2024-10-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMembersbh:HairColorMember2024-10-012025-03-310001368458us-gaap:SalesRevenueNetMembersbh:SkinAndCosmeticsMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2025-10-012026-03-310001368458us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherLiabilitiesMember2026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:StylingToolsAndSuppliesMembersbh:BeautySystemsGroupMember2026-01-012026-03-310001368458us-gaap:SalesRevenueNetMembersbh:OtherBeautyItemsMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2024-10-012025-03-310001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:StylingToolsAndSuppliesMembersbh:BeautySystemsGroupMember2025-10-012026-03-310001368458us-gaap:RetainedEarningsMember2025-09-3000013684582024-09-300001368458us-gaap:AdditionalPaidInCapitalMember2025-10-012025-12-310001368458us-gaap:CommonStockMember2025-10-012025-12-310001368458us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:AccruedLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember2025-09-300001368458sbh:SallyBeautySupplyMember2026-03-310001368458us-gaap:InterestRateSwapMembersbh:SallyHoldingsMember2024-10-012025-03-3100013684582023-04-012023-04-300001368458us-gaap:SalesRevenueNetMembersbh:OtherBeautyItemsMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMember2025-10-012026-03-310001368458sbh:AssetBasedSeniorSecuredLoanFacilityMember2026-03-310001368458us-gaap:CommonStockMember2025-12-310001368458us-gaap:ForeignExchangeContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2026-01-012026-03-310001368458us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2026-03-310001368458us-gaap:RetainedEarningsMember2025-12-310001368458sbh:SallyBeautySupplyMemberus-gaap:OperatingSegmentsMember2025-10-012026-03-310001368458us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherLiabilitiesMember2025-09-300001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300001368458us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeContractMember2026-03-310001368458us-gaap:FairValueMeasurementsRecurringMember2026-03-310001368458us-gaap:CommonStockMember2024-12-310001368458us-gaap:OperatingSegmentsMember2024-10-012025-03-3100013684582026-03-310001368458us-gaap:SalesRevenueNetMembersbh:OtherBeautyItemsMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2025-01-012025-03-310001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001368458us-gaap:AdditionalPaidInCapitalMember2024-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:NailMembersbh:BeautySystemsGroupMember2025-01-012025-03-310001368458us-gaap:AccumulatedTranslationAdjustmentMember2025-09-300001368458currency:MXN2026-03-310001368458us-gaap:InterestRateSwapMembersbh:SallyHoldingsMember2025-01-012025-03-3100013684582024-12-310001368458us-gaap:OperatingSegmentsMembersbh:BeautySystemsGroupMember2026-01-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2025-01-012025-03-310001368458sbh:SallyBeautySupplyMemberus-gaap:OperatingSegmentsMember2025-01-012025-03-310001368458us-gaap:FairValueInputsLevel2Memberus-gaap:OtherAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2025-09-300001368458sbh:SallyHoldingsMembersbh:TLBTwentyThirtyMember2025-10-012026-03-310001368458sbh:AccumulatedForeignExchangeContractsMember2025-09-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMembersbh:HairCareMember2025-10-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:NailMember2024-10-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:SalonBusinessConsultantsMember2024-10-012025-03-310001368458us-gaap:CommonStockMember2026-01-012026-03-310001368458us-gaap:RetainedEarningsMember2025-01-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:NailMember2025-10-012026-03-310001368458us-gaap:InterestRateSwapMember2025-10-012026-03-310001368458us-gaap:InterestRateSwapMembersbh:SallyHoldingsMember2023-04-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2024-10-012025-03-3100013684582024-10-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:OtherBeautyItemsMembersbh:SallyMember2026-01-012026-03-310001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001368458us-gaap:ForeignExchangeContractMember2026-03-310001368458us-gaap:FairValueInputsLevel2Membersbh:TermLoanBDueTwoThousandAndThirtyMember2025-09-300001368458us-gaap:RetainedEarningsMember2024-09-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:NailMember2025-01-012025-03-310001368458us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeContractMember2025-10-012026-03-310001368458us-gaap:AdditionalPaidInCapitalMember2024-10-012024-12-310001368458sbh:ShareRepurchaseProgram2017Member2017-08-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMembersbh:NailMember2024-10-012025-03-310001368458us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:StylingToolsAndSuppliesMember2026-01-012026-03-310001368458us-gaap:RetainedEarningsMember2025-10-012025-12-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:HairColorMember2026-01-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMember2025-01-012025-03-310001368458us-gaap:RetainedEarningsMember2026-01-012026-03-310001368458us-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2026-03-310001368458us-gaap:RetainedEarningsMember2024-12-310001368458us-gaap:OperatingSegmentsMember2025-10-012026-03-310001368458sbh:BeautySystemsGroupMember2026-03-310001368458us-gaap:FairValueInputsLevel2Memberus-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMember2026-03-310001368458sbh:SallyBeautySupplyMember2024-10-012025-09-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:ECommerceMember2024-10-012025-03-310001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-10-012025-12-310001368458us-gaap:CommonStockMember2025-03-310001368458us-gaap:SalesRevenueNetMembersbh:SkinAndCosmeticsMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2024-10-012025-03-310001368458us-gaap:FranchisedUnitsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMember2025-10-012026-03-310001368458sbh:AccumulatedForeignExchangeContractsMember2026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:HairColorMember2025-01-012025-03-310001368458us-gaap:SalesRevenueNetMembersbh:SkinAndCosmeticsMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMember2026-01-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMember2026-01-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:ECommerceMember2026-01-012026-03-310001368458sbh:ShareRepurchaseProgram2017Member2025-05-012025-05-310001368458us-gaap:SalesRevenueNetMembersbh:SkinAndCosmeticsMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMember2025-01-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMembersbh:SallyMemberus-gaap:EntityOperatedUnitsMember2025-10-012026-03-310001368458us-gaap:AdditionalPaidInCapitalMember2025-09-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMembersbh:SalonBusinessConsultantsMember2025-10-012026-03-310001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001368458currency:CAD2026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:NailMembersbh:BeautySystemsGroupMember2025-10-012026-03-310001368458us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:ForeignExchangeContractMember2026-01-012026-03-310001368458us-gaap:FairValueInputsLevel2Memberus-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:FairValueMeasurementsRecurringMember2025-09-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMember2026-01-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:HairCareMember2026-01-012026-03-310001368458us-gaap:SalesRevenueNetMembersbh:SkinAndCosmeticsMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMember2024-10-012025-03-310001368458us-gaap:FairValueMeasurementsRecurringMember2025-09-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMembersbh:HairCareMember2025-01-012025-03-310001368458sbh:DentonTexasMember2024-10-012024-10-310001368458us-gaap:OperatingSegmentsMembersbh:BeautySystemsGroupMember2025-10-012026-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMembersbh:BeautySystemsGroupMemberus-gaap:EntityOperatedUnitsMember2024-10-012025-03-310001368458us-gaap:InterestRateSwapMembersbh:SallyHoldingsMember2023-04-012023-04-300001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:SallyMembersbh:HairCareMember2024-10-012025-03-310001368458us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesChannelDirectlyToConsumerMembersbh:BeautySystemsGroupMemberus-gaap:EntityOperatedUnitsMember2025-01-012025-03-310001368458us-gaap:OperatingSegmentsMember2026-01-012026-03-310001368458us-gaap:LineOfCreditMember2026-03-310001368458sbh:ShareRepurchaseProgram2017Member2025-01-012025-03-3100013684582025-10-012026-03-310001368458us-gaap:FranchisedUnitsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMembersbh:BeautySystemsGroupMemberus-gaap:SalesChannelThroughIntermediaryMember2024-10-012025-03-310001368458sbh:UnallocatedMember2025-01-012025-03-310001368458us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-31xbrli:puresbh:Segmentxbrli:sharessbh:Instrumentiso4217:USDxbrli:sharesiso4217:USD

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED: MARCH 31, 2026

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File No. 1-33145

 

SALLY BEAUTY HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware

36-2257936

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

7900 Windrose Ave

Plano, Texas

75024

(Address of principal executive offices)

(Zip Code)

 

(800) 777-5706

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, $0.01 par value

SBH

The New York Stock Exchange

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

Number of shares of common stock outstanding as of May 6, 2026: 95,408,486

 

 


 

TABLE OF CONTENTS

 

Page

PART I — FINANCIAL INFORMATION

 

 

 

Item 1. Financial Statements

4

 

 

Condensed Consolidated Balance Sheets

4

Condensed Consolidated Statements of Earnings

5

Condensed Consolidated Statements of Comprehensive Income

6

Condensed Consolidated Statements of Stockholders’ Equity

7

Condensed Consolidated Statements of Cash Flows

8

Notes to Condensed Consolidated Financial Statements

9

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

16

Item 3. Quantitative and Qualitative Disclosures About Market Risk

23

Item 4. Controls and Procedures

23

 

PART II — OTHER INFORMATION

 

 

 

Item 1. Legal Proceedings

24

Item 1A. Risk Factors

24

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities.

24

Item 5. Other Information

24

Item 6. Exhibits

25

 

 

2


 

In this Quarterly Report, references to the “Company,” “our company,” “Sally Beauty,” “we,” “our,” “ours” and “us” refer to Sally Beauty Holdings, Inc. and its consolidated subsidiaries unless otherwise indicated or the context otherwise requires.

cautionary notice regarding forward-looking statements

Statements in this Quarterly Report on Form 10-Q and in the documents incorporated by reference herein which are not purely historical facts or which depend upon future events may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “project,” “target,” “can,” “could,” “may,” “should,” “will,” “would,” "might" or similar expressions may also identify such forward-looking statements.

Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The most important factors which could cause our actual results to differ from our forward-looking statements are set forth in our description of risk factors in Item 1A contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, and other filings with the U.S. Securities and Exchange Commission ("SEC") which should be read in conjunction with the forward-looking statements in this report. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update any forward-looking statement.

The events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. As a result, our actual results may differ materially from the results contemplated by these forward-looking statements.

3


 

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements.

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands, except par value data)

 

 

 

March 31,
2026

 

 

September 30,
2025

 

 

 

(Unaudited)

 

 

 

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

157,401

 

 

$

149,162

 

Trade accounts receivable, net

 

 

26,231

 

 

 

31,828

 

Accounts receivable, other

 

 

75,401

 

 

 

84,734

 

Inventory

 

 

986,787

 

 

 

987,575

 

Other current assets

 

 

46,940

 

 

 

48,154

 

Total current assets

 

 

1,292,760

 

 

 

1,301,453

 

Property and equipment, net of accumulated depreciation of $963,117 at
   March 31, 2026, and $
937,596 at September 30, 2025

 

 

285,335

 

 

 

284,284

 

Operating lease assets

 

 

635,406

 

 

 

646,698

 

Goodwill

 

 

539,061

 

 

 

540,674

 

Intangible assets, excluding goodwill, net of accumulated amortization of
   $
9,052 at March 31, 2026, and $14,686 at September 30, 2025

 

 

51,375

 

 

 

53,018

 

Other assets

 

 

49,353

 

 

 

44,969

 

Total assets

 

$

2,853,290

 

 

$

2,871,096

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Current maturities of long-term debt

 

$

4,000

 

 

$

4,000

 

Accounts payable

 

 

222,635

 

 

 

224,507

 

Accrued liabilities

 

 

169,800

 

 

 

184,641

 

Current operating lease liabilities

 

 

157,050

 

 

 

158,566

 

Income taxes payable

 

 

 

 

 

4,260

 

Total current liabilities

 

 

553,485

 

 

 

575,974

 

Long-term debt

 

 

823,051

 

 

 

861,974

 

Long-term operating lease liabilities

 

 

531,987

 

 

 

538,426

 

Other liabilities

 

 

21,080

 

 

 

21,026

 

Deferred income tax liabilities, net

 

 

85,815

 

 

 

79,489

 

Total liabilities

 

 

2,015,418

 

 

 

2,076,889

 

Stockholders’ equity:

 

 

 

 

 

 

Common stock, $0.01 par value. Authorized 500,000 shares; 95,898 
  and
97,875 shares issued and shares outstanding at March 31, 2026,
  and September 30, 2025, respectively

 

 

959

 

 

 

979

 

Preferred stock, $0.01 par value. Authorized 50,000 shares; none issued

 

 

 

 

 

 

Accumulated earnings

 

 

946,455

 

 

 

898,076

 

Accumulated other comprehensive loss, net of tax

 

 

(109,542

)

 

 

(104,848

)

Total stockholders’ equity

 

 

837,872

 

 

 

794,207

 

Total liabilities and stockholders’ equity

 

$

2,853,290

 

 

$

2,871,096

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4


 

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Earnings

(In thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

March 31,

 

 

March 31,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net sales

 

$

903,382

 

 

$

883,146

 

 

$

1,846,550

 

 

$

1,821,041

 

Cost of goods sold

 

 

427,610

 

 

 

424,329

 

 

 

887,519

 

 

 

885,384

 

Gross profit

 

 

475,772

 

 

 

458,817

 

 

 

959,031

 

 

 

935,657

 

Selling, general and administrative expenses

 

 

403,841

 

 

 

389,444

 

 

 

811,165

 

 

 

765,964

 

Operating earnings

 

 

71,931

 

 

 

69,373

 

 

 

147,866

 

 

 

169,693

 

Interest expense

 

 

14,165

 

 

 

16,289

 

 

 

28,785

 

 

 

33,731

 

Earnings before provision for income taxes

 

 

57,766

 

 

 

53,084

 

 

 

119,081

 

 

 

135,962

 

Provision for income taxes

 

 

15,071

 

 

 

13,874

 

 

 

30,829

 

 

 

35,739

 

Net earnings

 

$

42,695

 

 

$

39,210

 

 

$

88,252

 

 

$

100,223

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.44

 

 

$

0.39

 

 

$

0.91

 

 

$

0.98

 

Diluted

 

$

0.43

 

 

$

0.38

 

 

$

0.88

 

 

$

0.96

 

Weighted-average shares:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

96,727

 

 

 

101,614

 

 

 

97,271

 

 

 

101,820

 

Diluted

 

 

99,721

 

 

 

104,435

 

 

 

100,265

 

 

 

104,682

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

5


 

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income

(In thousands)

(Unaudited)

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

March 31,

 

 

March 31,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net earnings

 

$

42,695

 

 

$

39,210

 

 

$

88,252

 

 

$

100,223

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

(9,079

)

 

 

10,791

 

 

 

(4,692

)

 

 

(15,824

)

Interest rate swap, net of tax

 

 

90

 

 

 

(407

)

 

 

(49

)

 

 

744

 

Foreign exchange contracts, net of tax

 

 

163

 

 

 

(581

)

 

 

47

 

 

 

902

 

Other comprehensive income (loss), net of tax

 

 

(8,826

)

 

 

9,803

 

 

 

(4,694

)

 

 

(14,178

)

Total comprehensive income

 

$

33,869

 

 

$

49,013

 

 

$

83,558

 

 

$

86,045

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

6


 

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Stockholders’ Equity

(In thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

Other

 

 

Total

 

 

Common Stock

Paid-in

 

 

Accumulated

 

 

Comprehensive

 

 

Stockholders’

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Earnings

 

 

Loss

 

 

Equity

 

Balance at September 30, 2025

 

97,875

 

 

$

979

 

 

$

 

 

$

898,076

 

 

$

(104,848

)

 

$

794,207

 

Net earnings

 

 

 

 

 

 

 

 

 

 

45,557

 

 

 

 

 

 

45,557

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

4,132

 

 

 

4,132

 

Share-based compensation

 

 

 

 

 

 

 

7,555

 

 

 

 

 

 

 

 

 

7,555

 

Stock issued for equity awards

 

1,493

 

 

 

15

 

 

 

192

 

 

 

 

 

 

 

 

 

207

 

Employee withholding taxes paid
   related to net share settlement

 

(517

)

 

 

(5

)

 

 

(7,331

)

 

 

 

 

 

 

 

 

(7,336

)

Repurchases and cancellations of
   common stock

 

(1,359

)

 

 

(14

)

 

 

(416

)

 

 

(20,327

)

 

 

 

 

 

(20,757

)

Balance at December 31, 2025

 

97,492

 

 

$

975

 

 

$

 

 

$

923,306

 

 

$

(100,716

)

 

$

823,565

 

Net earnings

 

 

 

 

 

 

 

 

 

 

42,695

 

 

 

 

 

 

42,695

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

(8,826

)

 

 

(8,826

)

Share-based compensation

 

 

 

 

 

 

 

5,969

 

 

 

 

 

 

 

 

 

5,969

 

Stock issued for equity awards

 

68

 

 

 

1

 

 

 

70

 

 

 

 

 

 

 

 

 

71

 

Employee withholding taxes paid
   related to net share settlement

 

(1

)

 

 

 

 

 

(9

)

 

 

 

 

 

 

 

 

(9

)

Repurchases and cancellations of
   common stock

 

(1,661

)

 

 

(17

)

 

 

(6,030

)

 

 

(19,546

)

 

 

 

 

 

(25,593

)

Balance at March 31, 2026

 

95,898

 

 

$

959

 

 

$

 

 

$

946,455

 

 

$

(109,542

)

 

$

837,872

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

Other

 

 

Total

 

 

Common Stock

Paid-in

 

 

Accumulated

 

 

Comprehensive

 

 

Stockholders’

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Earnings

 

 

Loss

 

 

Equity

 

Balance at September 30, 2024

 

101,854

 

 

$

1,019

 

 

$

 

 

$

740,685

 

 

$

(113,169

)

 

$

628,535

 

Net earnings

 

 

 

 

 

 

 

 

 

 

61,013

 

 

 

 

 

 

61,013

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

(23,981

)

 

 

(23,981

)

Share-based compensation

 

 

 

 

 

 

 

6,053

 

 

 

 

 

 

 

 

 

6,053

 

Stock issued for equity awards

 

1,162

 

 

 

12

 

 

 

69

 

 

 

 

 

 

 

 

 

81

 

Employee withholding taxes paid
   related to net share settlement

 

(392

)

 

 

(4

)

 

 

(5,260

)

 

 

 

 

 

 

 

 

(5,264

)

Repurchases and cancellations of
   common stock

 

(753

)

 

 

(8

)

 

 

(862

)

 

 

(9,078

)

 

 

 

 

 

(9,948

)

Balance at December 31, 2024

 

101,871

 

 

$

1,019

 

 

$

 

 

$

792,620

 

 

$

(137,150

)

 

$

656,489

 

Net earnings

 

 

 

 

 

 

 

 

 

 

39,210

 

 

 

 

 

 

39,210

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

9,803

 

 

 

9,803

 

Share-based compensation

 

 

 

 

 

 

 

4,238

 

 

 

 

 

 

 

 

 

4,238

 

Stock issued for equity awards

 

112

 

 

 

1

 

 

 

321

 

 

 

 

 

 

 

 

 

322

 

Employee withholding taxes paid
   related to net share settlement

 

(1

)

 

 

 

 

 

(7

)

 

 

 

 

 

 

 

 

(7

)

Repurchases and cancellations of
   common stock

 

(1,088

)

 

 

(11

)

 

 

(4,552

)

 

 

(5,676

)

 

 

 

 

 

(10,239

)

Balance at March 31, 2025

 

100,894

 

 

$

1,009

 

 

$

 

 

$

826,154

 

 

$

(127,347

)

 

$

699,816

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

7


 

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

 

Six Months Ended March 31,

 

 

 

2026

 

 

2025

 

Cash Flows from Operating Activities:

 

 

 

 

 

 

Net earnings

 

$

88,252

 

 

$

100,223

 

Adjustments to reconcile net earnings to net cash provided
    by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

48,912

 

 

 

50,924

 

Share-based compensation expense

 

 

13,524

 

 

 

10,291

 

Amortization of deferred financing costs

 

 

965

 

 

 

1,092

 

Loss on early extinguishment of debt

 

 

296

 

 

 

759

 

Impairment of long-lived assets

 

 

 

 

 

1,779

 

Loss (gain) on disposal of equipment and other property

 

 

11

 

 

 

(26,641

)

Deferred income taxes

 

 

6,208

 

 

 

(4,581

)

Changes in (exclusive of effects of acquisitions):

 

 

 

 

 

 

Trade accounts receivable

 

 

5,517

 

 

 

5,779

 

Accounts receivable, other

 

 

8,910

 

 

 

(9,751

)

Inventory

 

 

(1,750

)

 

 

20,759

 

Other current assets

 

 

1,148

 

 

 

6,138

 

Other assets

 

 

(4,548

)

 

 

666

 

Operating leases, net

 

 

3,411

 

 

 

(509

)

Accounts payable and accrued liabilities

 

 

7

 

 

 

(57,761

)

Income taxes payable

 

 

(4,400

)

 

 

(13,583

)

Other liabilities

 

 

56

 

 

 

(1,063

)

Net cash provided by operating activities

 

 

166,519

 

 

 

84,521

 

Cash Flows from Investing Activities:

 

 

 

 

 

 

Payments for property and equipment

 

 

(64,946

)

 

 

(38,971

)

Proceeds from sale of property and equipment, net

 

 

 

 

 

43,574

 

Acquisitions, net of cash acquired

 

 

 

 

 

(371

)

Net cash (used) provided by investing activities

 

 

(64,946

)

 

 

4,232

 

Cash Flows from Financing Activities:

 

 

 

 

 

 

Proceeds from issuance of long-term debt and ABL Facility

 

 

 

 

 

351,000

 

Repayments of long-term debt and ABL Facility

 

 

(40,000

)

 

 

(428,079

)

Debt issuance costs

 

 

 

 

 

(1,525

)

Proceeds from equity awards

 

 

278

 

 

 

403

 

Payments for common stock repurchased

 

 

(46,349

)

 

 

(20,187

)

Employee withholding taxes paid related to net share settlement of equity awards

 

 

(7,345

)

 

 

(5,271

)

Net cash used by financing activities

 

 

(93,416

)

 

 

(103,659

)

Effect of foreign exchange rate changes on cash and cash equivalents

 

 

82

 

 

 

(881

)

Net increase (decrease) in cash and cash equivalents

 

 

8,239

 

 

 

(15,787

)

Cash and cash equivalents, beginning of period

 

 

149,162

 

 

 

107,961

 

Cash and cash equivalents, end of period

 

$

157,401

 

 

$

92,174

 

Supplemental Cash Flow Information:

 

 

 

 

 

 

Interest paid

 

$

28,529

 

 

$

33,344

 

Income taxes paid

 

$

33,752

 

 

$

55,815

 

Capital expenditures incurred but not paid

 

$

8,129

 

 

$

6,999

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

8


 

Sally Beauty Holdings, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1. Significant Accounting Policies

Basis of Presentation

The unaudited condensed consolidated interim financial statements of Sally Beauty Holdings, Inc. and its subsidiaries included herein have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted, although we believe that the disclosures included herein are adequate for the interim period presented. These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025. In the opinion of management, these unaudited condensed consolidated interim financial statements reflect all adjustments that are of a normal recurring nature and that are necessary to present fairly our consolidated financial position as of March 31, 2026, and September 30, 2025, our consolidated results of operations, consolidated comprehensive income, consolidated statements of stockholders’ equity for the three and six months ended March 31, 2026 and 2025, and consolidated cash flows for the six months ended March 31, 2026 and 2025.

Principles of Consolidation

The unaudited condensed consolidated interim financial statements include all accounts of Sally Beauty Holdings, Inc. and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. All amounts are presented in U.S. Dollars.

Accounting Policies

We adhere to the same accounting policies in the preparation of our condensed consolidated interim financial statements as we do in the preparation of our full year consolidated financial statements. As permitted under GAAP, interim accounting for certain expenses, including income taxes, is based on full-year assumptions. For interim financial reporting purposes, income taxes are recorded based upon our estimated annual effective income tax.

Use of Estimates

In order to present our unaudited condensed consolidated interim financial statements in conformity with GAAP, we are required to make certain estimates and assumptions that impact our interim financial statements and supplementary disclosures. These estimates may use forecasted financial information based on reasonable assumptions available at the time of preparation, however, actual results could differ due to changes in facts and circumstances. Significant estimates and assumptions are involved in the accounting for sales allowances, deferred revenue, valuation of inventory, amortization and depreciation, intangible assets and goodwill, and other reserves. We believe these estimates and assumptions are reasonable based on management’s knowledge of current events and anticipated further actions, and changes in facts and circumstances may result in revised estimates and impact actual results. Revisions to estimates are recognized in the period in which the facts that give rise to the change become known.

2. Recent Accounting Pronouncements

In December 2023, the FASB issued accounting standards update (“ASU”) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to expand disclosures in an entity’s income tax rate reconciliation table and the disaggregation of taxes paid in U.S. and foreign jurisdictions. The amendments in this update are effective for annual periods beginning after December 15, 2024. The new standard is not expected to have a material impact on our consolidated financial statements; however, we expect to provide additional detail and disclosures upon adoption.

In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income: Expense Disaggregation Disclosures (Subtopic 220-40), which requires, among other things, more detailed disclosure about types of expenses in commonly presented expense captions such as cost of goods sold and selling, general and administrative expenses. The update is intended to improve disclosures by providing amounts related to inventory purchases, employee compensation, depreciation, and amortization. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted, but we currently do not expect to early adopt this standard. We are currently evaluating the impact of this update to our consolidated financial statements and disclosures.

9


 

3. Revenue Recognition

Substantially all of our revenue is derived through the sale of merchandise at the point-of-sale in our stores or when products are shipped for e-commerce orders. Revenue is recognized net of estimated sales returns and sales taxes, when control of the merchandise is transferred to the customer. We estimate sales returns based on historical data.

Changes to our contract liabilities, which are included in accrued liabilities in our condensed consolidated balance sheets, were as follows (in thousands):

 

 

 

 

 

 

Six Months Ended March 31,

 

 

 

 

 

 

 

2026

 

 

2025

 

Beginning Balance

 

 

 

 

 

$

10,027

 

 

$

11,493

 

Loyalty points and gift cards issued but not redeemed, net of estimated breakage

 

 

5,071

 

 

 

4,545

 

Revenue recognized from beginning liability

 

 

(5,594

)

 

 

(4,618

)

Ending Balance

 

 

 

 

 

$

9,504

 

 

$

11,420

 

See Note 12, Segment Reporting, for additional information regarding the disaggregation of our sales revenue.

4. Fair Value Measurements

We measure on a recurring basis and disclose the fair value of our financial instruments under the provisions of ASC Topic 820, Fair Value Measurement, as amended (“ASC 820”). We define “fair value” as the price that would be received to sell an asset or paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-level hierarchy for measuring fair value and requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. This valuation hierarchy is based upon the transparency of inputs used in the valuation of an asset or liability on the measurement date.

The three levels of that hierarchy are defined as follows:

Level 1 - Quoted prices are available in active markets for identical assets or liabilities;

Level 2 - Pricing inputs are other than quoted prices in active markets, included in Level 1, that are either directly or indirectly observable; and

Level 3 - Unobservable pricing inputs in which little or no market activity exists, therefore requiring an entity to develop its own model with estimates and assumptions.

Financial instruments measured at fair value on recurring basis

Consistent with the fair value hierarchy, we categorized our financial assets and liabilities as follows:

(in thousands)

 

Classification

 

Fair Value Hierarchy Level

 

March 31,
2026

 

 

September 30,
2025

 

Financial Assets:

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

 

 

 

 

 

 

 

 

 

Designated cash flow hedges

 

 Other current assets

 

Level 2

 

$

64

 

 

$

87

 

Non-designated cash flow hedges

 

 Other current assets

 

Level 2

 

 

735

 

 

 

570

 

Interest rate swap

 

 Other assets

 

Level 2

 

 

 

 

 

59

 

Total assets

 

 

 

 

 

$

799

 

 

$

716

 

.

 

 

 

 

 

 

 

 

 

 

Financial Liabilities:

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

 

 

 

 

 

 

 

 

 

Designated cash flow hedges

 

 Accrued liabilities

 

Level 2

 

$

351

 

 

$

57

 

Non-designated cash flow hedges

 

 Accrued liabilities

 

Level 2

 

 

379

 

 

 

225

 

Interest rate swap

 

 Other Liabilities

 

Level 2

 

 

6

 

 

 

 

Total liabilities

 

 

 

 

 

$

736

 

 

$

282

 

The fair value of each asset and liability was determined using widely accepted valuation techniques, including discounted cash flow analyses and observable inputs, such as market interest rates and foreign exchange rates.

10


 

Other fair value disclosures

The carrying amounts, if any, of cash equivalents, trade and other accounts receivable, accounts payable, and borrowings under our $500 million asset-based senior secured loan facility (the “ABL Facility”) approximate their respective fair values due to the short-term nature of these financial instruments. The carrying amounts and corresponding estimated fair values of our long-term debt, excluding debt issuance costs and original issue discounts, are as follows:

 

 

Fair Value

 

March 31, 2026

 

 

September 30, 2025

 

(in thousands)

 

Hierarchy Level

 

Carrying Value

 

 

Fair Value

 

 

Carrying Value

 

 

Fair Value

 

Long-term debt

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Senior notes due 2032

 

Level 2

 

$

600,000

 

 

$

612,000

 

 

$

600,000

 

 

$

622,500

 

Term loan B due 2030

 

Level 2

 

 

235,000

 

 

 

234,413

 

 

 

275,000

 

 

 

276,375

 

Total long-term debt

 

 

 

$

835,000

 

 

$

846,413

 

 

$

875,000

 

 

$

898,875

 

 

The fair value of our senior notes was determined using unadjusted quoted market prices. The fair value of our Term Loan B agreement was determined using unadjusted quoted market prices for similar debt securities in active markets.

5. Stockholders’ Equity

Share Repurchases

In August 2017, our Board of Directors (the “Board”) approved a share repurchase program authorizing us to repurchase up to $1.0 billion of our common stock, subject to certain limitations governed by our debt agreements. In May 2025, our Board approved a term extension of our share repurchase program to September 30, 2029. Under this extension the Company is authorized to purchase its common stock up to the amount remaining under the Board’s 2017 authorization. As of March 31, 2026, we had approximately $421.3 million of additional share repurchase authorizations remaining under our share repurchase program. For the three and six months ended March 31, 2026, we repurchased 1.7 million shares and 3.0 million shares of our common stock at a total cost of $25.4 million and $46.0 million, respectively, excluding the impact of excise taxes. For the three and six months ended March 31, 2025, we repurchased 1.1 million shares and 1.8 million shares of our common stock at a total cost of $10.0 million and $20.0 million, respectively, excluding the impact of excise taxes.

Accumulated Other Comprehensive Loss

The change in accumulated other comprehensive loss (“AOCL”) was as follows (in thousands):

 

 

Foreign Currency Translation Adjustments

 

 

Interest Rate Swap

 

 

Foreign Exchange Contracts

 

 

Total

 

 

Balance at September 30, 2025

 

$

(104,329

)

 

$

84

 

 

$

(603

)

 

$

(104,848

)

 

Other comprehensive income (loss) before
    reclassification, net of tax

 

 

(4,692

)

 

 

55

 

 

 

(371

)

 

 

(5,008

)

 

Reclassification to net earnings, net of tax

 

 

 

 

 

(104

)

 

 

418

 

 

 

314

 

 

Balance at March 31, 2026

 

$

(109,021

)

 

$

35

 

 

$

(556

)

 

$

(109,542

)

 

The tax impacts for the changes in other comprehensive income (loss) and the reclassifications to net earnings were not material.

6. Weighted-Average Shares

The following table presents a reconciliation of basic and diluted weighted-average shares (in thousands):

 

 

Three Months Ended
March 31,

 

 

Six Months Ended
March 31,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Weighted-average basic shares

 

 

96,727

 

 

 

101,614

 

 

 

97,271

 

 

 

101,820

 

Dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

Stock option and stock award programs

 

 

2,994

 

 

 

2,821

 

 

 

2,994

 

 

 

2,862

 

Weighted-average diluted shares

 

 

99,721

 

 

 

104,435

 

 

 

100,265

 

 

 

104,682

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Anti-dilutive options excluded from our computation of diluted shares

 

 

1,251

 

 

 

1,528

 

 

 

1,251

 

 

 

1,528

 

 

11


 

7. Property and Equipment, Net

In October 2024, we sold our corporate headquarters located in Denton, Texas to Denton County, Texas for $45.5 million, excluding $1.5 million in closing costs. As a result of the sale, we recognized a gain of approximately $26.6 million within selling, general and administrative expenses in our condensed consolidated statements of earnings for the six months ended March 31, 2025.

8. Goodwill and Intangible Assets

As of January 31, 2026, we completed our annual assessments for impairment of goodwill and indefinite-lived intangible assets. For our goodwill testing, we performed a qualitative analysis and determined that there was no indication of impairment. For our indefinite-lived intangible asset assessment, we performed a quantitative analysis and determined that there was no impairment. No impairment losses were recognized in the current or prior periods presented in connection with our goodwill. In the prior year, we recognized a $1.8 million impairment loss in selling, general, and administrative expenses related to a trade name within the Sally reporting segment.

Goodwill allocated to our Sally and BSG reporting units, which are also defined as our Sally and BSG segments, was $89.8 million and $449.2 million, respectively, as of March 31, 2026. For the six months ended March 31, 2026, changes in goodwill reflect the effects of foreign currency exchange rates of $1.6 million.

 

The following table presents our amortization expense for the period (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

Six Months Ended
March 31,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Intangible assets amortization expense

 

$

653

 

 

$

841

 

 

$

1,305

 

 

$

1,699

 

 

9. Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

 

 

March 31,
2026

 

 

September 30,
2025

 

Compensation and benefits

 

$

73,927

 

 

$

85,058

 

Deferred revenue

 

 

14,443

 

 

 

14,195

 

Rental obligations

 

 

11,700

 

 

 

10,286

 

Accrued freight

 

 

7,733

 

 

 

8,761

 

Insurance reserves

 

 

7,153

 

 

 

7,331

 

Interest payable

 

 

3,780

 

 

 

3,819

 

Operating accruals and other

 

 

51,064

 

 

 

55,191

 

Total accrued liabilities

 

$

169,800

 

 

$

184,641

 

 

 

 

 

 

 

 

 

10. Short-term and Long-term Debt

At March 31, 2026, there were no outstanding borrowings under our ABL Facility, and we had $482.3 million available for borrowing, including under our Canadian sub-facility, subject to a borrowing base limitation, as reduced by outstanding letters of credit.

During the three and six months ended March 31, 2026, we voluntarily repaid $19.0 million and $38.0 million, respectively, of outstanding Term Loan B principal in addition to our mandatory quarterly payment. In connection with the voluntary repayments, we recognized a $0.1 million loss and a $0.3 million loss on debt extinguishment within interest expense related to unamortized debt issuance costs for the three and six months ended March 31, 2026, respectively.

11. Derivative Instruments and Hedging Activities

During the six months ended March 31, 2026, we did not purchase or hold any derivative instruments for trading or speculative purposes. See Note 4, Fair Value Measurements, for the classification and fair value of our derivative instruments.

12


 

Designated Cash Flow Hedges

Foreign Currency Forwards

We regularly enter into foreign currency forwards to mitigate our exposure to exchange rate changes on forecasted inventory purchases in U.S. dollars by our foreign subsidiaries. At March 31, 2026, we held forwards, which expire ratably through September 30, 2026, with a notional amount, based upon exchange rates at March 31, 2026, as follows (in thousands):

Notional Currency

 

Notional Amount

 

Mexican Peso

 

$

9,548

 

Canadian Dollar

 

 

4,469

 

Total

 

$

14,017

 

 

The changes in fair value related to these foreign currency forwards are recorded quarterly into AOCL. As the forwards are exercised, the realized gains or losses are recognized into cost of goods sold (“COGS”), based on inventory turns, in our condensed consolidated statements of earnings. For the three months ended March 31, 2026 and 2025, we recognized a net loss of $0.2 million and a net gain of $0.3 million, respectively. For the six months ended March 31, 2026 and 2025, we recognized a net loss of $0.5 million and a net gain of $0.1 million, respectively. Based on March 31, 2026, valuations and exchange rates, we expect to reclassify a net gain of approximately $0.4 million out of AOCL and into COGS over the next 12 months.

Interest Rate Swap

In April 2023, we entered into a three-year interest rate swap agreement with an initial notional amount of $200 million (the “Interest Rate Swap”) to mitigate the exposure to higher interest rates in connection with our Term Loan B due in 2030. The Interest Rate Swap involves fixed monthly payments at the contract rate of 3.705%, and in return, we will receive a floating interest payment based on the 1-month Adjusted Term SOFR Rate. The Interest Rate Swap will mature in April 2026 and is designated as a cash flow hedge. Changes in the fair value of the Interest Rate Swap are recorded quarterly, net of income tax, and included in AOCL.

Each month, we recognize either income or expense, based on the position of the interest rates, into interest expense on our condensed consolidated statements of earnings related to the Interest Rate Swap. For the three months ended March 31, 2026 and 2025, we recognized expense of $0.1 million and income of $0.4 million, respectively. For the six months ended March 31, 2026 and 2025, we recognized income of $0.1 million and $0.9 million, respectively. At March 31, 2026, we expect to reclassify a net loss of approximately $0.1 million out of AOCL and into interest expense over the next 12 months.

Non-Designated Derivative Instruments

We also use foreign exchange forward contracts to mitigate our exposure to exchange rate fluctuations related to certain intercompany balances that are not considered permanently invested. At March 31, 2026, we held forward contracts, which mature at various dates during the first month of each of the next two fiscal quarters, with a notional amount, based upon exchange rates at March 31, 2026, as follows (in thousands):

Notional Currency

 

Notional Amount

 

British Pound

 

$

48,308

 

Euro

 

 

18,024

 

Canadian Dollar

 

 

11,643

 

Mexican Peso

 

 

1,715

 

Total

 

$

79,690

 

Changes in the fair value of the forward contracts, as well as realized gains or losses upon settlement, are recorded in selling, general and administrative expenses. For the three months ended March 31, 2026 and 2025, the effects of these foreign exchange contracts on our condensed consolidated financial statements were a net gain of $0.4 million and a loss of $0.7 million, respectively. For the six months ended March 31, 2026 and 2025, the effects of these foreign exchange contracts on our condensed consolidated financial statements were net gains of $0.1 million and $1.0 million, respectively.

12. Segment Reporting

Our business is organized into two reportable segments: (i) Sally, a domestic and international chain of retail stores and digital platforms that offers professional beauty supplies to both salon professionals and retail customers primarily in North America, including Puerto Rico, and parts of Europe and South America and, (ii) BSG, including its franchise-based business Armstrong McCall, a full service distributor of beauty products and supplies that offers professional beauty products directly to salons and salon professionals through its professional-only stores, its own sales force, and digital platforms in partially exclusive geographical territories in the U.S., including Puerto Rico, and Canada.

Our Chief Operating Decision Maker ("CODM"), whom we have determined to be our Chief Executive Officer, regularly evaluates

13


 

the performance of our reportable segments by comparing current segment operating earnings to comparable prior periods and forecasted amounts. Included within segment operating earnings, the significant expense categories below are regularly provided to the CODM.

Segment Operating Performance

The following tables summarize our results for the three and six months ended March 31, 2026 and 2025 (in thousands):

`

 

Three Months Ended March 31, 2026

 

 

Three Months Ended March 31, 2025

 

 

 

Sally

 

 

BSG

 

 

Total

 

 

Sally

 

 

BSG

 

 

Total

 

Net sales (a)

 

$

521,236

 

 

$

382,146

 

 

$

903,382

 

 

$

500,575

 

 

$

382,571

 

 

$

883,146

 

Less: (b)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

 

201,904

 

 

 

225,706

 

 

 

427,610

 

 

 

194,178

 

 

 

230,151

 

 

 

424,329

 

Selling, general, and administrative expenses

 

 

241,183

 

 

 

109,072

 

 

 

350,255

 

 

 

229,092

 

 

 

108,486

 

 

 

337,578

 

Segment operating earnings

 

 

78,149

 

 

 

47,368

 

 

 

125,517

 

 

 

77,305

 

 

 

43,934

 

 

 

121,239

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unallocated expenses (c)

 

 

 

 

 

 

 

 

53,586

 

 

 

 

 

 

 

 

 

51,866

 

Interest expense

 

 

 

 

 

 

 

 

14,165

 

 

 

 

 

 

 

 

 

16,289

 

Earnings before provision for income taxes

 

 

 

 

 

 

 

$

57,766

 

 

 

 

 

 

 

 

$

53,084

 

 

 

`

 

Six Months Ended March 31, 2026

 

 

Six Months Ended March 31, 2025

 

 

 

Sally

 

 

BSG

 

 

Total

 

 

Sally

 

 

BSG

 

 

Total

 

Net sales (a)

 

$

1,052,837

 

 

$

793,713

 

 

$

1,846,550

 

 

$

1,026,021

 

 

$

795,020

 

 

$

1,821,041

 

Less: (b)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

 

415,563

 

 

 

471,956

 

 

 

887,519

 

 

 

406,368

 

 

 

479,016

 

 

 

885,384

 

Selling, general, and administrative expenses

 

 

481,228

 

 

 

220,482

 

 

 

701,710

 

 

 

462,474

 

 

 

221,601

 

 

 

684,075

 

Segment operating earnings

 

 

156,046

 

 

 

101,275

 

 

 

257,321

 

 

 

157,179

 

 

 

94,403

 

 

 

251,582

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unallocated expenses (c)

 

 

 

 

 

 

 

 

109,455

 

 

 

 

 

 

 

 

 

81,889

 

Interest expense

 

 

 

 

 

 

 

 

28,785

 

 

 

 

 

 

 

 

 

33,731

 

Earnings before provision for income taxes

 

 

 

 

 

 

 

$

119,081

 

 

 

 

 

 

 

 

$

135,962

 

 

(a)
There were no intersegment sales between our segments, nor did any single customer account for 10% or more of revenue.
(b)
The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(c)
Unallocated expenses consist of corporate and shared costs, including certain costs associated with our Fuel for Growth initiative, and are included in selling, general and administrative expenses in our condensed consolidated statements of earnings. For the six months ended March 31, 2025, unallocated expenses included a $26.6 million gain related to the sale of our corporate headquarters. See Note 7, Property and Equipment, Net, for more information.


Other Segment Disclosures

 

 

 

Three Months Ended March 31,

 

 

Six Months Ended March 31,

 

(in thousands)

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Depreciation and amortization:

 

 

 

 

 

 

 

 

 

 

 

 

Sally

 

$

14,306

 

 

$

14,074

 

 

$

27,738

 

 

$

28,732

 

BSG

 

 

9,006

 

 

 

9,765

 

 

 

17,680

 

 

 

18,252

 

Unallocated

 

 

1,968

 

 

 

1,520

 

 

 

3,494

 

 

 

3,940

 

Total

 

$

25,280

 

 

$

25,359

 

 

$

48,912

 

 

$

50,924

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14


 

Disaggregation of net sales by segment

The following tables disaggregate our segment revenues by merchandise category.

 

 

Three Months Ended March 31,

 

 

Six Months Ended March 31,

 

Sally

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Hair color

 

 

45.1

%

 

 

42.3

%

 

 

44.0

%

 

 

41.3

%

Hair care

 

 

21.5

%

 

 

23.6

%

 

 

21.8

%

 

 

23.7

%

Styling tools and supplies

 

 

16.1

%

 

 

16.2

%

 

 

16.7

%

 

 

16.8

%

Nail

 

 

9.9

%

 

 

10.0

%

 

 

9.9

%

 

 

10.0

%

Skin and cosmetics

 

 

7.1

%

 

 

7.4

%

 

 

7.3

%

 

 

7.6

%

Other beauty items

 

 

0.3

%

 

 

0.5

%

 

 

0.3

%

 

 

0.6

%

Total

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

 

Three Months Ended March 31,

 

 

Six Months Ended March 31,

 

BSG

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Hair color

 

 

43.8

%

 

 

42.8

%

 

 

42.7

%

 

 

41.4

%

Hair care

 

 

40.8

%

 

 

40.9

%

 

 

41.8

%

 

 

41.9

%

Styling tools and supplies

 

 

10.1

%

 

 

10.5

%

 

 

10.1

%

 

 

10.6

%

Skin and cosmetics

 

 

2.9

%

 

 

3.4

%

 

 

3.2

%

 

 

3.6

%

Nail

 

 

2.1

%

 

 

2.2

%

 

 

2.0

%

 

 

2.3

%

Other beauty items

 

 

0.3

%

 

 

0.2

%

 

 

0.2

%

 

 

0.2

%

Total

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

The following tables disaggregate our segment revenue by sales channels:

 

 

Three Months Ended March 31,

 

 

Six Months Ended March 31,

 

Sally

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Company-operated stores

 

 

90.3

%

 

 

91.8

%

 

 

90.4

%

 

 

92.0

%

E-commerce

 

 

9.7

%

 

 

8.2

%

 

 

9.6

%

 

 

8.0

%

Total

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

 

Three Months Ended March 31,

 

 

Six Months Ended March 31,

 

BSG

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Company-operated stores

 

 

69.3

%

 

 

69.3

%

 

 

69.3

%

 

 

69.4

%

E-commerce

 

 

14.9

%

 

 

13.9

%

 

 

14.8

%

 

 

14.0

%

Salon business consultants

 

 

8.4

%

 

 

9.3

%

 

 

8.5

%

 

 

9.5

%

Franchise stores

 

 

7.4

%

 

 

7.5

%

 

 

7.4

%

 

 

7.1

%

Total

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

15


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This section discusses management’s view of the financial condition, results of operations and cash flows of Sally Beauty for the periods covered by this Quarterly Report. This section should be read in conjunction with the information contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, including the Risk Factors sections therein, and information contained elsewhere in this Quarterly Report, including the condensed consolidated interim financial statements and notes to those financial statements.

Financial Summary for the Three Months Ended March 31, 2026

Consolidated net sales for the three months ended March 31, 2026, increased $20.2 million, or 2.3%, to $903.4 million, compared to the three months ended March 31, 2025. Consolidated net sales included a positive impact from changes in foreign currency exchange rates of $12.8 million;
Consolidated comparable sales were 1.3% for the three months ended March 31, 2026;
Consolidated gross profit for the three months ended March 31, 2026, increased $17.0 million, or 3.7%, to $475.8 million, compared to the three months ended March 31, 2025. Consolidated gross margin increased 70 bps to 52.7% for the three months ended March 31, 2026, compared to the three months ended March 31, 2025;
Consolidated operating earnings for the three months ended March 31, 2026, increased $2.6 million, or 3.7%, to $71.9 million, compared to the three months ended March 31, 2025. Operating margin increased 10 bps to 8.0% for the three months ended March 31, 2026, compared to the three months ended March 31, 2025;
For the three months ended March 31, 2026, our consolidated net earnings increased $3.5 million, or 8.9%, to $42.7 million, compared to the three months ended March 31, 2025;
For the three months ended March 31, 2026, our diluted earnings per share was $0.43 compared to $0.38 for the three months ended March 31, 2025; and
Cash provided by operations was $73.3 million for the three months ended March 31, 2026, compared to $51.1 million for the three months ended March 31, 2025.

Comparable Sales

We believe that comparable sales is an appropriate performance indicator to measure our sales growth compared to the prior period. Our comparable sales include sales from stores that have been operating for 14 months or longer as of the last day of a month and from e-commerce revenue. Additionally, comparable sales include sales to franchisees and full service sales. Our comparable sales excludes the effect of changes in foreign exchange rates and sales from stores relocated until 14 months after the relocation. Revenue from acquired stores is excluded from our comparable sales calculation until 14 months after the acquisition. Our calculation of comparable sales might not be the same as other retailers as the calculation varies across the retail industry.

16


 

Overview

Key Operating Metrics

The following table sets forth, for the periods indicated, information concerning key measures on which we rely to evaluate our operating performance (dollars in thousands):

 

 

Three Months Ended March 31,

 

 

Six Months Ended March 31,

 

 

 

2026

 

 

2025

 

 

Increase (Decrease)

 

 

2026

 

 

2025

 

 

Increase (Decrease)

 

Net sales:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sally

 

$

521,236

 

 

$

500,575

 

 

$

20,661

 

 

 

4.1

%

 

$

1,052,837

 

 

$

1,026,021

 

 

$

26,816

 

 

 

2.6

%

BSG

 

 

382,146

 

 

 

382,571

 

 

 

(425

)

 

 

(0.1

)%

 

 

793,713

 

 

 

795,020

 

 

 

(1,307

)

 

 

(0.2

)%

Consolidated

 

$

903,382

 

 

$

883,146

 

 

$

20,236

 

 

 

2.3

%

 

$

1,846,550

 

 

$

1,821,041

 

 

$

25,509

 

 

 

1.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sally

 

$

319,332

 

 

$

306,397

 

 

$

12,935

 

 

 

4.2

%

 

$

637,274

 

 

$

619,653

 

 

$

17,621

 

 

 

2.8

%

BSG

 

 

156,440

 

 

 

152,420

 

 

 

4,020

 

 

 

2.6

%

 

 

321,757

 

 

 

316,004

 

 

 

5,753

 

 

 

1.8

%

Consolidated

 

$

475,772

 

 

$

458,817

 

 

$

16,955

 

 

 

3.7

%

 

$

959,031

 

 

$

935,657

 

 

$

23,374

 

 

 

2.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment gross margin:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sally

 

 

61.3

%

 

 

61.2

%

 

10

 

 

 bps

 

 

 

60.5

%

 

 

60.4

%

 

10

 

 

 bps

 

BSG

 

 

40.9

%

 

 

39.8

%

 

110

 

 

 bps

 

 

 

40.5

%

 

 

39.7

%

 

80

 

 

 bps

 

Consolidated

 

 

52.7

%

 

 

52.0

%

 

70

 

 

 bps

 

 

 

51.9

%

 

 

51.4

%

 

50

 

 

 bps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment operating earnings:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sally

 

$

78,149

 

 

$

77,305

 

 

$

844

 

 

 

1.1

%

 

$

156,046

 

 

$

157,179

 

 

$

(1,133

)

 

 

(0.7

)%

BSG

 

 

47,368

 

 

 

43,934

 

 

 

3,434

 

 

 

7.8

%

 

 

101,275

 

 

 

94,403

 

 

 

6,872

 

 

 

7.3

%

Segment operating earnings

 

 

125,517

 

 

 

121,239

 

 

 

4,278

 

 

 

3.5

%

 

 

257,321

 

 

 

251,582

 

 

 

5,739

 

 

 

2.3

%

Unallocated expenses (a)

 

 

53,586

 

 

 

51,866

 

 

 

1,720

 

 

 

3.3

%

 

 

109,455

 

 

 

81,889

 

 

 

27,566

 

 

 

33.7

%

Consolidated operating earnings

 

 

71,931

 

 

 

69,373

 

 

 

2,558

 

 

 

3.7

%

 

 

147,866

 

 

 

169,693

 

 

 

(21,827

)

 

 

(12.9

)%

Interest expense

 

 

14,165

 

 

 

16,289

 

 

 

(2,124

)

 

 

(13.0

)%

 

 

28,785

 

 

 

33,731

 

 

 

(4,946

)

 

 

(14.7

)%

Earnings before provision for income taxes

 

 

57,766

 

 

 

53,084

 

 

 

4,682

 

 

 

8.8

%

 

 

119,081

 

 

 

135,962

 

 

 

(16,881

)

 

 

(12.4

)%

Provision for income taxes

 

 

15,071

 

 

 

13,874

 

 

 

1,197

 

 

 

8.6

%

 

 

30,829

 

 

 

35,739

 

 

 

(4,910

)

 

 

(13.7

)%

Net earnings

 

$

42,695

 

 

$

39,210

 

 

$

3,485

 

 

 

8.9

%

 

$

88,252

 

 

$

100,223

 

 

$

(11,971

)

 

 

(11.9

)%

 

 

.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comparable sales growth (decline):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sally

 

 

2.5

%

 

 

(0.3

)%

 

280

 

 

 bps

 

 

 

1.3

%

 

 

0.8

%

 

50

 

 

 bps

 

BSG

 

 

(0.3

)%

 

 

(2.7

)%

 

240

 

 

 bps

 

 

 

(0.2

)%

 

 

(0.6

)%

 

40

 

 

 bps

 

Consolidated

 

 

1.3

%

 

 

(1.3

)%

 

260

 

 

 bps

 

 

 

0.6

%

 

 

0.2

%

 

40

 

 

 bps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of stores at end-of-period (including franchises):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sally

 

 

3,079

 

 

 

3,117

 

 

 

(38

)

 

 

(1.2

)%

 

 

 

 

 

 

 

 

 

 

 

 

BSG

 

 

1,320

 

 

 

1,329

 

 

 

(9

)

 

 

(0.7

)%

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated

 

 

4,399

 

 

 

4,446

 

 

 

(47

)

 

 

(1.1

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

(a)
Unallocated expenses consist of corporate and shared costs and are included in selling, general and administrative expenses in our condensed consolidated statements of earnings. Additionally, unallocated expenses include certain costs associated with our Fuel for Growth initiative as well as the $26.6 million gain related to the sale of our corporate headquarters during the six months ended March 31, 2025. See Note 7, Property and Equipment, Net, for more information related to the sale of our corporate headquarters.

17


 

Results of Operations

The Three Months Ended March 31, 2026, compared to the Three Months Ended March 31, 2025

Net Sales

Sally. The increase in net sales for Sally was primarily driven by the following (in thousands):

Comparable sales

 

$

12,498

 

Sales outside comparable sales (a)

 

 

(3,323

)

Foreign currency exchange

 

 

11,486

 

Total

 

$

20,661

 

(a)
Includes closed stores, net of stores opened for less than 14 months.

Sally's net sales increase was primarily driven by an increase in comparable sales and positive impacts from foreign exchange rates, partially offset by net stores closed during the past twelve months. The increase in comparable sales was primarily driven by strong growth in hair color and digital marketplaces, partially offset by softness in our hair care category and the strategic exit of the majority of our full service operations across Europe. Sally’s comparable sales reflect increases in our number of transactions and average unit retail.

BSG. The decrease in net sales for BSG was primarily driven by the following (in thousands):

Comparable sales

 

$

(1,118

)

Sales outside comparable sales (a)

 

 

(660

)

Foreign currency exchange

 

 

1,353

 

Total

 

$

(425

)

(a)
Includes closed stores, net of stores opened for less than 14 months and sales from acquired stores.

BSG's net sales decrease was primarily from a decrease in comparable sales, partially offset by positive impacts from foreign exchange rates. The decrease in comparable sales was driven by external factors that impacted stylist purchasing behavior, partially offset by strong performance in our color category. BSG's comparable sales were slightly down with a decrease in the average number of units per transaction, offset by a higher average unit retail.

Gross Profit

Sally. Sally’s gross profit increased for the three months ended March 31, 2026, as a result of an increase in net sales and a higher gross margin on units sold. Sally’s gross margin improvement was driven primarily by higher product margins, resulting from benefits from our Fuel for Growth initiative, partially offset by impacts of the write-off of certain inventory related to the strategic exit of the majority of all our low-margin full service operations in Europe in connection with our Fuel for Growth initiative.

BSG. BSG’s gross profit increased for the three months ended March 31, 2026, as a result of a higher gross margin on units sold, partially offset by a decrease in net sales. BSG’s gross margin improvement was driven by higher product margins, resulting from benefits from our Fuel for Growth initiative.

Selling, General and Administrative Expenses

Sally. Sally’s selling, general and administrative expenses increased $12.1 million, or 5.3%, for the three months ended March 31, 2026, and included an unfavorable impact from foreign exchange rates of $5.5 million. As a percentage of Sally net sales, selling, general and administrative expenses for the three months ended March 31, 2026, were 46.3%, compared to 45.8% for the three months ended March 31, 2025. The increase as a percentage of sales was primarily due to increased labor and other compensation-related expenses, higher commission costs from digital marketplaces, and higher rent and advertising expenses, partially offset by leveraging as a result of higher net sales, impacts of an impairment charge related to a trade name (non-cash expense of $1.8 million) in the prior year, and Fuel for Growth benefits.

BSG. BSG’s selling, general and administrative expenses increased $0.6 million, or 0.5%, for the three months ended March 31, 2026. As a percentage of BSG net sales, selling, general and administrative expenses for the three months ended March 31, 2026, were 28.5% compared to 28.4% for the three months ended March 31, 2025. The increase as a percentage of sales was primarily due to higher labor and other compensation-related expenses and rent expense, partially offset by lower depreciation and amortization expenses.

Unallocated. Unallocated selling, general and administrative expenses, which represent certain corporate costs that have not been charged to our reporting segments, increased $1.7 million, or 3.3%, for the three months ended March 31, 2026, primarily due to an increased labor and other compensation-related expenses, higher information technology expense, and higher facility expenses related to our new corporate headquarters, partially offset by lower expenses related to our Fuel for Growth initiative.

18


 

Interest Expense

The decrease in interest expense was primarily a result of a lower average outstanding principal balance on our Term Loan B. See Note 10, Short-term and Long-term Debt, in Item 1 of this quarterly report for more information on our debt.

Provision for Income Taxes

The effective tax rate was 26.1% for the three months ended March 31, 2026 and 2025. The effective tax rate remained unchanged, primarily due to a decrease related to foreign operations in the current quarter, offset by the unfavorable tax impact of executive compensation.

The Six Months Ended March 31, 2026, compared to the Six Months Ended March 31, 2025

Net Sales

Sally. The increase in net sales for Sally was primarily driven by the following (in thousands):

Comparable sales

 

$

13,077

 

Sales outside comparable sales (a)

 

 

(6,118

)

Foreign currency exchange

 

 

19,857

 

Total

 

$

26,816

 

(a)
Includes closed stores, net of stores opened for less than 14 months.

Sally's net sales increase was primarily driven by positive impacts from foreign exchange rates and an increase in comparable sales, partially offset by net stores closed during the past twelve months. The increase in comparable sales was primarily driven by strong growth in hair color and digital marketplaces, partially offset by external factors that impacted consumer spending, including the U.S. government shutdown during the beginning of our fiscal year, softness in our hair care category, and the strategic exit of the majority of our full service operations across Europe. Sally’s comparable sales reflect increases in our average unit retail and number of transactions, partially offset by fewer average number of units per transaction.

BSG. The decrease in net sales for BSG was primarily driven by the following (in thousands):

Comparable sales

 

$

(1,870

)

Sales outside comparable sales (a)

 

 

(932

)

Foreign currency exchange

 

 

1,495

 

Total

 

$

(1,307

)

(a)
Includes closed stores, net of stores opened for less than 14 months and sales from acquired stores.

BSG's net sales decrease was primarily from a decrease in comparable sales. The decrease in comparable sales was driven by external factors that impacted stylist purchasing behavior, including the U.S. government shutdown during the beginning of our fiscal year, partially offset by strong performance in our color category. BSG's comparable sales decrease was primarily a result of a decrease in the number of transactions and average number of units per transaction, partially offset by an increase in average unit retail.

Gross Profit

Sally. Sally’s gross profit increased for the six months ended March 31, 2026, as a result of an increase in net sales and a higher gross margin on units sold. Sally’s gross margin improvement was driven primarily by higher product margins, resulting from benefits from our Fuel for Growth initiative, partially offset by impacts of the write-off of certain inventory related to the strategic exit of the majority of our low-margin full service operations in Europe in connection with our Fuel for Growth initiative.

BSG. BSG’s gross profit increased for the six months ended March 31, 2026, as a result of a higher gross margin on units sold, partially offset by a decrease in net sales. BSG’s gross margin improvement was driven by higher product margins, resulting from benefits from our Fuel for Growth initiative.

Selling, General and Administrative Expenses

Sally. Sally’s selling, general and administrative expenses increased $18.8 million, or 4.1%, for the six months ended March 31, 2026, and included an unfavorable impact from foreign exchange rates of $3.5 million. As a percentage of Sally net sales, selling, general and administrative expenses for the six months ended March 31, 2026, were 45.7%, compared to 45.1% for the six months ended March 31, 2025. The increase as a percentage of sales was primarily due to higher labor and other compensation-related expenses, higher commission costs from digital marketplaces, and higher rent and advertising expenses, partially offset by leveraging as a result of higher net sales, impacts of an impairment charge related to a trade name (non-cash expense of $1.8 million) in the prior year, and Fuel for Growth benefits.

19


 

BSG. BSG’s selling, general and administrative expenses decreased $1.1 million, or 0.5%, for the six months ended March 31, 2026. As a percentage of BSG net sales, selling, general and administrative expenses for the six months ended March 31, 2026, were 27.8% compared to 27.9% for the six months ended March 31, 2025. The decrease as a percentage of sales was primarily due to lower depreciation and amortization expenses, partially offset by higher labor and other compensation-related expenses and rent expense.

Unallocated. Unallocated selling, general and administrative expenses, which represent certain corporate costs that have not been charged to our reporting segments, increased $27.6 million or 33.7%, for the six months ended March 31, 2026, primarily due to a $26.6 million gain on the sale of our corporate headquarters in the prior year, higher facility expenses related to our new corporate headquarters, higher labor and other compensation-related expenses, and an increase in information technology expenses, partially offset by lower costs in connection with our Fuel for Growth initiative.

Interest Expense

The decrease in interest expense was primarily a result of a lower average outstanding principal balance on our Term Loan B. See Note 10, Short-term and Long-term Debt, in Item 1 of this quarterly report for more information on our debt.

Provision for Income Taxes

The effective tax rates were 25.9% and 26.3% for the six months ended March 31, 2026 and 2025, respectively. The decrease in the effective tax rate was primarily attributable to foreign operations and a more favorable tax impact of share‑based compensation in the current year, offset by higher federal tax credits in the prior year.

Liquidity and Capital Resources

Overview

Our principal sources of liquidity are cash from operations, cash and cash equivalents and borrowings under our ABL Facility. A substantial portion of our liquidity needs arise from funding the costs of our operations, working capital, capital expenditures, debt interest and principal payments. Additionally, under our share repurchase program (see below for more details) we will from time to time repurchase shares of our common stock on the open market to return value to our shareholders. At March 31, 2026, we had $639.7 million of available liquidity, which includes $482.3 million available for borrowing under our ABL Facility and cash and cash equivalents of $157.4 million.

Our working capital (current assets less current liabilities) increased $13.8 million, to $739.3 million at March 31, 2026, compared to $725.5 million at September 30, 2025. The increase was primarily driven by the timing of accrued compensation and benefit expenses within accrued expenses and an increase in cash and cash equivalents, partially offset by the timing of landlord receivables related to our new corporate headquarters within accounts receivable, other.

We anticipate that existing cash balances (excluding certain amounts permanently invested in connection with foreign operations), cash expected to be generated by operations, and funds available under our ABL Facility will be sufficient to fund our working capital and capital expenditure requirements over the next twelve months.

Cash Flows

 

 

Six Months Ended March 31,

 

(in thousands)

 

2026

 

 

2025

 

Net cash provided by operating activities

 

$

166,519

 

 

$

84,521

 

Net cash (used) provided by investing activities

 

 

(64,946

)

 

 

4,232

 

Net cash used by financing activities

 

 

(93,416

)

 

 

(103,659

)

Net Cash Provided by Operating Activities

The increase in cash provided by operating activities was primarily driven by the timing of accounts payable, an increase in cash receipts from customers, lower income taxes paid, and the receipt of landlord receivables related to our new corporate headquarters, partially offset by strategic reduction in slower moving inventory in the prior year while maintaining consistent inventory levels this year.

Net Cash (Used) Provided by Investing Activities

The change in our investing activities was a result of lapping the cash received of $44 million from the sale of our corporate headquarters in the prior year and higher capital expenditures in the current year, which includes the build out of our new corporate headquarters.

Net Cash Used by Financing Activities

The decrease in cash used by financing activities was primarily driven by lower debt repayments in the current year, partially offset by higher share repurchases under our share repurchase program.

20


 

Debt and Guarantor Financial Information

At March 31, 2026, we had $835.0 million in outstanding debt principal, excluding unamortized debt issuance costs and debt discounts, in the aggregate, of $7.9 million. Our debt consists of $600.0 million in 2032 Senior Notes outstanding, and $235.0 million remaining on our Term Loan B.

We utilize our ABL Facility for the issuance of letters of credit, certain working capital and liquidity needs, and to manage normal fluctuations in our operational cash flow. In that regard, we may from time to time draw funds under the ABL Facility for general corporate purposes including funding of capital expenditures, acquisitions, paying down other debt and share repurchases. Amounts drawn on our ABL Facility are generally paid down with cash provided by our operating activities. During the six months ended March 31, 2026, there were no borrowings under the ABL Facility.

We are currently in compliance with the agreements and instruments governing our debt, including our financial covenants.

Guarantor Financial Information

Our 2032 Senior Notes were issued by our wholly owned subsidiaries, Sally Holdings LLC and Sally Capital Inc. (together, the “Issuers”). The notes are unsecured debt instruments guaranteed by us and certain of our wholly owned domestic subsidiaries (together, the “Guarantors”) and have certain restrictions on the ability of our subsidiaries to make certain restrictive payments to Sally Beauty. The guarantees are joint and several, and full and unconditional. Certain other subsidiaries, including our foreign subsidiaries, do not serve as guarantors.

The following summarized consolidating financial information represents financial information for the Issuers and the Guarantors on a combined basis. All transactions and intercompany balances between these combined entities have been eliminated.

The following table presents the summarized balance sheets information for the Issuers and the Guarantors as of March 31, 2026, and September 30, 2025:

(in thousands)

 

March 31, 2026

 

 

September 30, 2025

 

Cash and cash equivalents

 

$

94,276

 

 

$

85,360

 

Inventory

 

$

729,427

 

 

$

721,975

 

Current assets

 

$

927,458

 

 

$

927,667

 

Total assets

 

$

2,176,114

 

 

$

2,177,968

 

Intercompany payable

 

$

17,941

 

 

$

15,117

 

Current liabilities

 

$

467,406

 

 

$

474,079

 

Total liabilities

 

$

1,839,552

 

 

$

1,883,754

 

The following table presents the summarized statement of earnings information for the Issuers and the Guarantors for the six months ended March 31, 2026 (in thousands):

Net sales

 

$

1,492,172

 

 

Gross profit

 

$

789,221

 

 

Earnings before provision for income taxes

 

$

107,642

 

 

Net Earnings

 

$

80,021

 

 

Share Repurchase Programs

Under our current share repurchase program, we may from time to time repurchase our common stock on the open market. During the six months ended March 31, 2026 and 2025, we repurchased 3.0 million shares and 1.8 million shares of our common stock for $46.0 million and $20.0 million, respectively, under our share repurchase program, excluding the impact of excise taxes. See Note 5, Stockholders’ Equity, for more information about our share repurchase program.

Contractual Obligations

Other than our debt, as discussed above, there have been no material changes outside the ordinary course of our business to our contractual obligations since September 30, 2025.

Off-Balance Sheet Financing Arrangements

At March 31, 2026, and September 30, 2025, we had no off-balance sheet financing arrangements other than outstanding letters of credit related to inventory purchases and self-insurance programs.

Critical Accounting Estimates

There have been no material changes to our critical accounting estimates or assumptions since September 30, 2025.

21


 

Recent Accounting Pronouncements

See Note 2 of the Notes to Condensed Consolidated Financial Statements in Item 1 – “Financial Statements” in Part I – Financial Information.

22


 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As a multinational corporation, we are subject to certain market risks including foreign currency fluctuations, interest rates and government actions. There have been no material changes to our market risks from September 30, 2025. See our disclosures about market risks contained in Item 7A. “Quantitative and Qualitative Disclosures about Market Risk” in Part II of our Annual Report on Form 10-K for the fiscal year ended September 30, 2025.

Item 4. Controls and Procedures

Controls Evaluation and Related CEO and CFO Certifications. Our management, with the participation of our principal executive officer (“CEO”) and principal financial officer (“CFO”), conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2026. The controls evaluation was conducted by our Disclosure Committee, comprised of senior representatives from our finance, accounting, internal audit, and legal departments under the supervision of our CEO and CFO.

Certifications of our CEO and our CFO, which are required in accordance with Rule 13a-14 of the Exchange Act, are attached as exhibits to this Quarterly Report. This “Controls and Procedures” section includes the information concerning the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.

Limitations on the Effectiveness of Controls. We do not expect that our disclosure controls and procedures will prevent all errors and all fraud. A system of controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the system are met. Because of the limitations in all such systems, no evaluation can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. Furthermore, the design of any system of controls and procedures is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how unlikely. Because of these inherent limitations in a cost-effective system of controls and procedures, misstatements or omissions due to error or fraud may occur and not be detected.

Scope of the Controls Evaluation. The evaluation of our disclosure controls and procedures included a review of their objectives and design, our implementation of the controls and procedures and the effect of the controls and procedures on the information generated for use in this Quarterly Report. In the course of the evaluation, we sought to identify whether we had any data errors, control problems or acts of fraud and to confirm that appropriate corrective action, including process improvements, was being undertaken if needed. This type of evaluation is performed on a quarterly basis so that conclusions concerning the effectiveness of our disclosure controls and procedures can be reported in our Quarterly Reports on Form 10-Q and our Annual Reports on Form 10-K. Many of the components of our disclosure controls and procedures are also evaluated by our internal audit department, by our legal department and by personnel in our finance organization. The overall goals of these various evaluation activities are to monitor our disclosure controls and procedures on an ongoing basis and to maintain them as dynamic systems that change as conditions warrant.

Conclusions regarding Disclosure Controls. Based on the required evaluation of our disclosure controls and procedures, our CEO and CFO have concluded that, as of March 31, 2026, we maintain disclosure controls and procedures that are effective in providing reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting. During our most recent fiscal quarter, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

23


 

PART II — OTHER INFORMATION

We are involved, from time to time, in various claims and lawsuits incidental to the conduct of our business in the ordinary course. We carry insurance coverage in such amounts in excess of our self-insured retention as we believe to be reasonable under the circumstances and that may or may not cover any or all of our liabilities in respect of these matters. We do not believe that the ultimate resolution of these matters will have a material adverse impact on our consolidated financial position, cash flows or results of operations.

We are subject to a number of U.S., federal, state and local laws and regulations, as well as the laws and regulations applicable in each foreign country or jurisdiction in which we do business. These laws and regulations govern, among other things, the composition, packaging, labeling and safety of the products we sell, the methods we use to sell these products and the methods we use to import these products. We believe that we are in material compliance with such laws and regulations, although no assurance can be provided that this will remain true going forward.

Item 1A. Risk Factors

In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors contained in Item 1A. “Risk Factors” in Part I of our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, which could materially affect our business, financial condition or future results. There have been no material changes from the risk factors disclosed in such Annual Report. The risks described in such Annual Report and herein are not the only risks facing our company.

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

Information regarding shares of common stock we repurchased during the quarter ended March 31, 2026, excluding the impact of excise taxes, is as follows:

Fiscal Period

 

Total Number of Shares Purchased (1)

 

 

Average Price Paid per Share (2)

 

 

Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)(3)

 

 

Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs

 

Jan 1 - Jan 31, 2026

 

 

541,565

 

 

$

15.38

 

 

 

541,565

 

 

$

438,301,556

 

Feb 1 - Feb 28, 2026

 

 

500,967

 

 

 

15.95

 

 

 

500,967

 

 

 

430,310,537

 

Mar 1 - Mar 31, 2026

 

 

618,465

 

 

 

14.61

 

 

 

618,465

 

 

 

421,276,242

 

Total this quarter

 

 

1,660,997

 

 

$

15.26

 

 

 

1,660,997

 

 

$

421,276,242

 

 

(1)
The table above does not include 571 shares of our common stock surrendered by grantees during the quarter to satisfy tax withholding obligations due upon the vesting of equity-based awards under our share-based compensation plans.
(2)
The calculation of the average price paid per share includes the impact of commissions paid in connection with the shares repurchased.
(3)
In May 2025, our Board approved a term extension through September 30, 2029, of our share repurchase program to repurchase up to $1.0 billion of our common stock, which was originally approved in August 2017.

Item 5. Other Information

During the quarter ended March 31, 2026, no director or officer of the Company adopted, modified, or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as such terms are defined in Item 408(a) of Regulation S-K.

24


 

Item 6. Exhibits

 

Exhibit No.

Description

 

 

 

3.1

Third Restated Certificate of Incorporation of Sally Beauty Holdings, Inc., dated January 30, 2014, which is incorporated herein by reference from Exhibit 3.3 to the Company’s Current Report on Form 8-K filed on January 30, 2014

3.2

Amended and Restated By-Laws of Sally Beauty Holdings, Inc., dated July 2, 2025, which is incorporated herein by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on July 9, 2025

 

 

 

10.1*

 

Separation Agreement between Marlo Cormier and Sally Beauty Supply LLC, dated March 31, 2026

 

 

 

22*

 

List of Subsidiary Guarantors

 

 

 

31.1*

Rule 13a-14(a)/15d-14(a) Certification of Denise Paulonis

31.2*

Rule 13a-14(a)/15d-14(a) Certification of Adrianne Lee

32.1*

Section 1350 Certification of Denise Paulonis

32.2*

Section 1350 Certification of Adrianne Lee

 

 

 

101

The following financial information from our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Earnings; (iii) the Condensed Consolidated Statements of Comprehensive Income; (iv) the Condensed Consolidated Statements of Stockholders’ Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) the Notes to Condensed Consolidated Financial Statements.

 

 

 

104

The cover page from our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026, formatted in iXBRL (contained in Exhibit 101).

* Included herewith

 

25


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

SALLY BEAUTY HOLDINGS, INC.

 

 

 

(Registrant)

 

 

 

 

Date: May 11, 2026

 

 

 

 

 

 

 

 

By:

 

/s/ Adrianne Lee

 

 

 

Adrianne Lee

 

 

 

Senior Vice President, Chief Financial Officer

 

 

 

For the Registrant and as its Principal Financial Officer

 

26



ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

MARLO CORMIER SEPARATION AGREEMENT

LIST OF SUBSIDIARY GUARANTORS

CERTIFICATION OF THE CEO

CERTIFICATION OF THE CFO

SECTION 1350 CERTIFICATION OF THE CEO

SECTION 1350 CERTIFICATION OF THE CFO

XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: R22.htm

IDEA: R23.htm

IDEA: R24.htm

IDEA: R25.htm

IDEA: R26.htm

IDEA: R27.htm

IDEA: R28.htm

IDEA: R29.htm

IDEA: R30.htm

IDEA: R31.htm

IDEA: R32.htm

IDEA: R33.htm

IDEA: R34.htm

IDEA: R35.htm

IDEA: R36.htm

IDEA: R37.htm

IDEA: R38.htm

IDEA: R39.htm

IDEA: R40.htm

IDEA: R41.htm

IDEA: R42.htm

IDEA: R43.htm

IDEA: R44.htm

IDEA: R45.htm

IDEA: R46.htm

IDEA: R47.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: sbh-20260331_htm.xml